Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/06/034447
CTRI/2021/06/034447
Completed
Phase 4

ebulized dexmedetomidine for patients comfort and satisfaction during esophagogastroduodenoscopy-A double blind randomised controlled study

IMS and SUM Hospital0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Not specified
Sponsor
IMS and SUM Hospital
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
January 20, 2022
Last Updated
3 years ago
Study Type
Interventional

Investigators

Sponsor
IMS and SUM Hospital

Eligibility Criteria

Inclusion Criteria

  • •age 18 years to 65 years
  • •Elective esophagogastroduodenoscopy

Exclusion Criteria

  • •a therapeutic EGD, ASA\- Class 3 or higher, uncontrolled hypertension, seizure disorders, patient on anti\-depressants/anti\-psychotics, patients with a poor cardiopulmonary reserve and with body mass index (BMI) \>30 kg/m2, renal failure, decompensated cirrhosis, age less than 18 years or more than 65 years, being pregnant, or refusal to provide written informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
Emergence agitation after laparoscopic sleeve gastrectomySurgery
PACTR201601001408927faulty of medicine, ain shams university60
Completed
Phase 4
A clinical trial to study the effects of intravenous dexmedetomidine on patients comfort , sedation, haemodynamic stability during awake fiberoptic intubation in cervical mylopathy patients.
CTRI/2016/10/007410Bangur institute of nerosciences56
Not yet recruiting
Not Applicable
Study the effect of Dexmedetomidine Drug in preventing Confusional State and agitation that occurs in patients undergoing urological surgery under general anaesthesia.Health Condition 1: N998- Other intraoperative and postprocedural complications and disorders of genitourinary system
CTRI/2021/09/036789Institutional Review Board IRB
Not yet recruiting
Phase 3
Post operative dexmedetomidine nebulization for post operative pain managementHealth Condition 1: K80- Cholelithiasis
CTRI/2023/09/057764DEPARTMENT OF ANAESTHESIOLOGY, RAJENDRA INSTITUTE OF MEDICAL SCIENCES
Not yet recruiting
Phase 2
Role of drug ( dexmedetomidine) in controlling the intubation response.Health Condition 1: null- controlled diabetics, normal patients, male and female , 18-60 years of age.Health Condition 2: E119- Type 2 diabetes mellitus without complications
CTRI/2018/07/014837IZAMS INSTITUTE OF MEDICAL SCIENCES